Request Call Back

Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



If you believe Stroke was due to a drug you took, please list drug:

   * Please describe your case:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Stroke Disease Injury Lawsuits

Stroke | Lawsuits, Lawyers | Diseases: Injury, Infections | Atypical Antipsychotics, ADHD Drugs, HRT Drugs, COX-II Inhibitors

A stroke or (brain attack) takes place when a blood clot blocks a blood vessel or artery. Additionally a stroke can happen when a blood vessel breaks, disrupting blood flow to an area of the brain. When a brain attack occurs, brain cells are destroyed immediately in the area. These cells usually die within minutes to a few hours after a stroke starts. Strokes are the nation's third leading cause of death, behind Heart Disease and Cancer. Approximately 700,000 Americans each year suffer a new or recurrent stroke.

A stroke takes place nearly every 45 seconds. Strokes kill an estimated 163,000 people a year. Just about every 3 minutes someone dies from a stroke. Of every 5 deaths from a stroke, 3 occur in women and 2 in men. The 2002 stroke death rates per 100,000 populations for specific groups were 54 for white males, 53 for white females, 82 for African American males and 72 for African American females.

Ischemic strokes account for close to 83% of all cases. Ischemic strokes form as a result of an obstruction within a blood vessel supplying blood to the brain. The main condition for this type of obstruction is the development of fatty deposits lining the vessel walls. This condition is called atherosclerosis. These fatty deposits can cause two types of obstruction: cerebral thrombosis and cerebral embolism.

Cerebral thrombosis refers to a thrombus (blood clot) that develops at the clogged part of the vessel. Cerebral embolism refers to a blood clot that forms at another location in the circulatory system, usually the heart and large arteries of the neck and upper chest. Another major cause of embolism is an irregular heartbeat, known as atrial fibrillation. Conditions where clots can form in the heart, dislodge and travel to the brain are created.

Hemorrhagic strokes represent about 17% of stroke cases. Hemorrhagic strokes result from a weakened vessel that ruptures and bleeds into the surrounding brain. The blood accumulates and compresses the surrounding brain tissue. There are two types of hemorrhagic strokes: intracerebral hemorrhage and subarachnoid hemorrhage.

Hemorrhagic stroke occurs when a weakened blood vessel ruptures. Two types of weakened blood vessels usually cause hemorrhagic stroke: aneurysms and arteriovenous malformations (AVMs). An aneurysm is a ballooning of a weakened region of a blood vessel.  If left untreated, the aneurysm continues to weaken until it ruptures and bleeds into the brain.

An arteriovenous malformation (AVM) is a cluster of abnormally formed blood vessels. Any one of these vessels can rupture, also causing bleeding into the brain.  Transient ischemic attacks - Also called TIAs, transient ischemic attacks are minor or warning strokes. In a TIA, conditions indicative of an ischemic stroke are present and the typical stroke warning signs develop. However, the obstruction (blood clot) occurs for a short time and tends to resolve itself through normal mechanisms.

Symptoms of Strokes include: confusion, trouble speaking or understanding, trouble seeing in one or both eyes, numbness or weakness of face, arm or leg, especially on one side of the body, trouble walking, dizziness, loss of balance or coordination, severe headache with no known cause, vomiting, nausea, fever, fainting, coma and convulsions.

Another major contributing factor causing strokes in the use of prescription medcines. The below is a list of the drugs associated with stroke:

  • Attention Deficit Hyperactivity Disorder drugs: Adderall, Concerta, Cylert, Ritalin and Strattera
  • COX-II Inhibitors: Bextra, Celebrex and Vioxx
  • Hormone Replacement Therapy (HRT) drugs: Premarin, Premphase and Prempro
  • Atypical Antipsychotic drugs: Abilify, Clozaril, Geodon, Risperdal, Seroquel and Zyprexa

Legal Help For Victims Affected By Stroke

If you or a loved one has taken Atypical Antipsychotics, ADHD drugs, HRT drugs or COX-II Inhibitors and suffered a stroke, please fill out the form at the right for a free case evaluation by a qualified defective drug attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


StrokeRSS Feed

Beta Blockers Increase Surgery Risk

May 14, 2008 | Parker Waichman LLP
A new study on the effects of beta blockers and surgical procedures reveals that patients given a beta blocker—beta blockers are a type of blood pressure drug—to reduce heart risks prior to surgery, were one-third more likely to die within a month and also had double the risk of stroke compared with those who received a placebo, or a dummy pill.  The Canadian study appears in the journal, Lancet.  The study is the largest, most rigorous to date that reviews the effects of...

FDA Asks Novartis to Suspend Marketing of GI Drug Zelnorm

Apr 2, 2007 |
FDA Notified Novartis Pharmaceuticals Corporation The U.S. Food and Drug Administration (FDA) notified Novartis Pharmaceuticals Corporation that the company must cease its marketing of Zelnorm (tegaserod), a prescription drug used in the treatment of constipation and irritable bowel syndrome (IBS). According to the FDA, Zelmorm has been associated with an “increased risk of serious cardiovascular adverse events (heart problems).” Novartis has agreed to voluntarily suspend its...

Zelnorm is taken off the market

Mar 31, 2007 | Los Angeles Times
A Widely Prescribed Drug for Severe Constipation is being Taken Off the Market A widely prescribed drug for severe constipation is being taken off the market after it was linked to a higher risk of heart attacks and strokes, federal regulators said. Doctors said the voluntary withdrawal of Zelnorm by its manufacturer would leave few options for patients who suffer from a type of irritable bowel syndrome that affects about 12 million Americans, mostly women. "This is really a sort of...

Novartis to stop constipation drug sale

Mar 30, 2007 | AP
Swiss Pharmaceutical Maker Novartis AG Will Stop Selling A Drug Swiss pharmaceutical maker Novartis AG will stop selling a drug to relieve constipation after it was linked to a higher chance of heart attack, stroke and worsening heart chest pain that can become a heart attack, federal health officials said Friday. Novartis agreed to withdraw Zelnorm at the FDA's request, the agency said in a public health advisory. Zelnorm, also called tegaserod maleate, is a prescription medication...

FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)

Mar 9, 2007 |
U.S FDA Today Issued a Public Health Advisory Outlining New Safety Information The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia. The drugs affected by the safety update are darbepoetin alfa (Aranesp) and epoetin alfa (Epogen and Procrit). (ESAs are genetically engineered forms of the naturally...

More Stroke News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo